Manulife (Manufacturers Life Insurance)
ONCT

Manulife (Manufacturers Life Insurance)’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio ONCT Stock Details ONCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-3
Closed -$5K – 3977
2018
Q2 		$5K Hold
3
– – ﹤0.01% 4094
2018
Q1 		$6K Buy
3
+2
+200% +$4.46K ﹤0.01% 4081
2017
Q4 		$2K Sell
1
-9
-90% -$13K ﹤0.01% 4237
2017
Q3 		$12K Buy
10
+4
+67% +$3.6K ﹤0.01% 3784
2017
Q2 		$4K Hold
6
– – ﹤0.01% 4007
2017
Q1 		$4K Hold
6
– – ﹤0.01% 3835
2016
Q4 		$4K Hold
6
– – ﹤0.01% 4000
2016
Q3 		$6K Hold
6
– – ﹤0.01% 3838
2016
Q2 		$4K Hold
6
– – ﹤0.01% 3883
2016
Q1 		$4K Hold
6
– – ﹤0.01% 3845
2015
Q4 		$5 Hold
6
– – ﹤0.01% 3669
2015
Q3 		$6 Hold
6
– – ﹤0.01% 3655
2015
Q2 		$11 Buy
6
+5
+500% +$7.11K ﹤0.01% 3549
2015
Q1 		$1 Hold
1
– – ﹤0.01% 3922
2014
Q4 		$2 Hold
1
– – ﹤0.01% 3767
2014
Q3 		$2 Hold
1
– – ﹤0.01% 3788
2014
Q2 		$3K Hold
1
– – ﹤0.01% 3646
2014
Q1 		$3 Sell
1
-6
-86% -$14.9K ﹤0.01% 3593
2013
Q4 		$16 Sell
7
-9
-56% -$20.6K ﹤0.01% 3302
2013
Q3 		$46 Hold
16
– – ﹤0.01% 3136
2013
Q2 		$151K Buy
+16
New +$123K ﹤0.01% 2778

Other funds holding ONCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s ONCT Position: Q3 2018 in Review

Manulife (Manufacturers Life Insurance) sold out of Oncternal Therapeutics, Inc. Common Stock (ONCT) in Q3 2018, closing a stake of 3 shares — an estimated $5K sold.

Manulife (Manufacturers Life Insurance) first reported a position in ONCT in Q2 2013 and held it in 21 quarters. The position peaked at $151K in Q2 2013. 48 funds tracked by Wall St. Rank hold ONCT as of Q3 2018.

  • Manulife (Manufacturers Life Insurance) reported no remaining Oncternal Therapeutics, Inc. Common Stock position as of Q3 2018 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 3 Oncternal Therapeutics, Inc. Common Stock shares in Q3 2018, an estimated $5K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Oncternal Therapeutics, Inc. Common Stock in Q2 2013 and held it in 21 quarters.
  • Manulife (Manufacturers Life Insurance)'s Oncternal Therapeutics, Inc. Common Stock position peaked at $151K in Q2 2013.
  • 48 funds tracked by Wall St. Rank held Oncternal Therapeutics, Inc. Common Stock as of Q3 2018.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q3 2018, filed 14 Nov 2018.